NCT05798884 2023-04-05
Electro-acupuncture for the Prevention and Treatment of Oxaliplatin-induced Neurotoxicity in Colorectal Cancer Patients
Hong Kong Baptist University
Phase NA Unknown
Clinical Trials
12 trialsNCT00660842 2023-03-24
MITO-7
National Cancer Institute, Naples
Phase 3 Unknown
NCT05494320 2022-08-09
the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin
Ain Shams University
Unknown
NCT00807768 2019-03-20
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
GOG Foundation
Phase 3 Unknown
NCT01372787 2019-03-12
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
GOG Foundation
Unknown
NCT03330964 2017-11-06
Clinical Trial of Electroacupuncture Stimulation on Prevention and Treatment of Oxaliplatin Neurotoxicity
The First Affiliated Hospital of Dalian Medical University
Phase NA Unknown
NCT01882621 2016-06-01
Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients
Sun Yat-sen University
Phase 3 Unknown
NCT02024438 2015-09-28
Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT02500810 2015-07-17
Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT00436774 2013-08-12
Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01
National Cancer Institute (NCI)
Unknown
NCT00274885 2011-12-05
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
National Cancer Institute (NCI)
Phase 4 Unknown
NCT00884767 2009-07-08
Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin
National Cancer Institute (NCI)
Phase 2 Unknown